As the entries deadline draws near, we’re excited to say that Elsevier are kindly providing access to their complete R&D solutions portfolio to our two winners, an essential set of tools to support the startups on their journey.
Elsevier’s R&D Solutions is a portfolio of tools that integrate data, analytics and technology capabilities to help pharmaceutical & life sciences customers make data-driven drug discovery and development decisions. These tools help customers:
- streamline target selection and biomarker identification
- achieve more efficient hit identification and lead optimization
- make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs
- find partnerships and identify key opinion leaders to stay on the cutting edge of developing research
- and more ……
To find out more about Elsevier’s offerings go to https://www.elsevier.com/rd-solutions/pharma-and-life-sciences-solutions